Jiangsu Hengrui Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000014W7
CNY
61.62
7.26 (13.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
8,491.73
7,145.55
7,709.83
6,531.11
7,546.27
5,939.52
5,749.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
8,491.73
7,145.55
7,709.83
6,531.11
7,546.27
5,939.52
5,749.63
Raw Material Cost
1,147.04
1,169.40
1,105.25
1,050.13
1,018.93
1,031.32
990.81
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.74
10.92
2.25
0.00
3.31
0.00
1.16
Selling and Distribution Expenses
3,098.20
2,525.13
2,846.60
2,829.51
2,775.43
2,332.78
2,846.22
Other Expenses
161.39
144.22
196.00
143.93
174.66
115.24
114.73
Total Expenditure (Excl Depreciation)
5,859.86
5,147.63
5,914.11
5,318.97
5,544.26
4,516.51
4,985.45
Operating Profit (PBDIT) excl Other Income
2631.9
1997.8999999999999
1795.6999999999998
1212.1
2002
1423
764.2
Other Income
244.48
127.96
199.51
147.43
268.86
72.06
234.29
Operating Profit (PBDIT)
3,099.21
2,355.38
2,176.45
1,576.00
2,498.99
1,707.58
1,126.42
Interest
0.74
10.92
2.25
0.00
3.31
0.00
1.16
Exceptional Items
124.38
-13.11
99.10
1.99
0.20
7.34
-22.49
Gross Profit (PBDT)
7,344.69
5,976.15
6,604.58
5,480.97
6,527.34
4,908.20
4,758.82
Depreciation
230.90
230.90
223.00
223.00
212.41
212.41
222.45
Profit Before Tax
2,991.95
2,100.45
2,050.30
1,354.99
2,283.47
1,502.51
880.31
Tax
397.10
199.16
362.29
146.94
188.45
135.02
27.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,576.05
1,874.06
1,716.95
1,187.83
2,062.82
1,368.93
828.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,576.05
1,874.06
1,716.95
1,187.83
2,062.82
1,368.93
828.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.18
2.39
3.71
0.37
-2.18
-1.44
-1.87
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,578.23
1,876.44
1,720.66
1,188.20
2,060.64
1,367.49
826.79
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
58,464.83
46,987.06
45,519.86
43,767.91
42,622.24
41,873.50
40,465.80
Earnings per share (EPS)
0.4
0.3
0.27
0.19
0.32
0.22
0.13
Diluted Earnings per share
0.4
0.3
0.27
0.19
0.32
0.22
0.13
Operating Profit Margin (Excl OI)
30.9%
27.94%
22.75%
18.46%
26.74%
23.96%
11.65%
Gross Profit Margin
37.95%
32.63%
29.49%
24.16%
33.07%
28.87%
19.18%
PAT Margin
30.34%
26.23%
22.27%
18.19%
27.34%
23.05%
14.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 18.84% vs -7.32% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 37.40% vs 9.05% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 28.16% vs 12.67% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -93.58% vs 395.45% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Jiangsu Hengrui Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
8,491.73
0
8,491.73
Other Operating Income
0.00
0.00
0.00
Total Operating income
8,491.73
0
8,491.73
Raw Material Cost
1,147.04
0
1,147.04
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.74
0
0.74
Selling and Distribution Expenses
3,098.20
0
3,098.20
Other Expenses
161.39
0.00
161.39
Total Expenditure (Excl Depreciation)
5,859.86
0
5,859.86
Operating Profit (PBDIT) excl Other Income
2,631.88
0.00
2,631.88
Other Income
244.48
0
244.48
Operating Profit (PBDIT)
3,099.21
0
3,099.21
Interest
0.74
0
0.74
Exceptional Items
124.38
0
124.38
Gross Profit (PBDT)
7,344.69
0
7,344.69
Depreciation
230.90
0
230.90
Profit Before Tax
2,991.95
0
2,991.95
Tax
397.10
0
397.10
Provisions and contingencies
0
0
0.00
Profit After Tax
2,576.05
0
2,576.05
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,576.05
0
2,576.05
Share in Profit of Associates
0
0
0.00
Minority Interest
2.18
0
2.18
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,578.23
0
2,578.23
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
58,464.83
0
58,464.83
Earnings per share (EPS)
0.40
0
0.40
Diluted Earnings per share
0.40
0
0.40
Operating Profit Margin (Excl OI)
30.90%
0%
0.00
30.90%
Gross Profit Margin
37.95%
0%
0.00
37.95%
PAT Margin
30.34%
0%
0.00
30.34%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 849.17 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 18.84% vs -7.32% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 12.53% vs 34.34% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 257.82 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 37.40% vs 9.05% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 25.12% vs 94.95% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 285.47 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 28.16% vs 12.67% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 28.01% vs 91.33% in Jun 2024

Quarterly - Interest
Interest 0.07 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -93.58% vs 395.45% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -78.79% vs 22.22% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.90%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024